As shown in Figure 6a (NTCP/G2 infection system) and 6B (HB611), both drugs were supposed to be inhibitors of packaging as expected without significant change of sAg and/or eAg expression (Figures 4 and 5e,f). The gene discussed is SAG; the disease is infection.